diagnostics

29. März 2024

HEALTH DISCOVERY CORPORATION DEBUTS MELAPP 2 0 FOR IPHONE

08.02.12 | 14:31 Uhr

Health Discovery Corporation (OTCBB: HDVY), the molecular diagnostics company that launched the first SVM-based image analysis iPhone app for melanoma risk assessment, MelApp, today debuts MelApp 2.0 for iPhone. This updated version introduces a new Quiz feature that better educates users on melanoma cases with sample histories and provides the ability to practice assessing the risk Quelle: ad-hoc… [weiterlesen]

HEALTH DISCOVERY CORPORATION LAUNCHES ANDROID VERSION OF POPULAR MELAPP MELANOMA RISK ANALYSIS MOBILE PHONE APP

01.02.12 | 19:05 Uhr

Health Discovery Corporation (OTCBB: HDVY), the molecular diagnostics company that launched MelApp, the first SVM-based image analysis iPhone app for melanoma risk assessment, today debuts its popular MelApp mobile app for Android? devices. Now, health-conscious consumers can easily learn about melanoma and identify areas on their skin which may need attention from a specialist, Quelle: ad-hoc… [weiterlesen]

MELAPP FOR IPHONE APPLICATION RECEIVES RECORD DOWNLOADS FROM NATIONAL MAGAZINE COVERAGE

25.01.12 | 15:24 Uhr

Named one of the ?Top 10 Apps That Could Save Your Life? in the Jan. 22, 2012 issue of Parade Magazine, Health Discovery Corporation (OTCBB: HDVY), the molecular diagnostics company that launched MelApp in July 2011, the first SVM-based image analysis iPhone app for melanoma risk assessment, is pleased to announce it has received a record number of downloads in the days following the article. Quelle: ad-hoc… [weiterlesen]